Nearly 44% of primary care visits for Medicare fee-for-service beneficiaries were telehealth visits in April, up from 0.1% in February, according to a report released this week by the Department of Health and Human Services.

Medicare fee-for-service telehealth visits for primary care climbed from about 14,000 per week before the COVID-19 pandemic to 1.3 million per week in April, HHS said.

The Centers for Medicare & Medicaid Services has waived Medicare geographic and originating site restrictions on telehealth and expanded the list of telehealth-eligible services and practitioners during the emergency.

HHS Secretary Alex Azar said the report “shows that Medicare providers and beneficiaries rapidly embraced these new opportunities. The meteoric rise of telehealth during the pandemic has not only helped us combat the virus, but also prompted a new conversation around the future of patient-centered care."

AHA has urged Congress and the Administration to ensure flexibilities remain in place after the public health emergency, as well as to reimburse virtual services on par with in-person care. For more information, see the new AHA factsheet on the future of telehealth.

Related News Articles

Headline
The Coalition to Strengthen America’s Healthcare Sept. 18 sponsored an event with Politico in Washington, D.C. to discuss innovations in telehealth, artificial…
Headline
The AHA Sept. 17 urged the Department of Health and Human Services’ Office of Inspector General to further scrutinize policies and practices by certain…
Headline
The Centers for Medicare & Medicaid services Sept. 10 announced the opening of a 60-day public comment period regarding its proposed plan for new data…
Headline
The House Education and Workforce Committee advanced several bills Sept. 11, including legislation that would empower commercial insurance companies at the…
Headline
Hospitals and health systems are seeing significant increases in administrative costs, including due to burdensome practices by commercial insurers that often…
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…